Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patientsNorma Rallón, Vincent Soriano, Susanna Naggie et al.|AIDS|2010Cited by 202
Rate and predictors of progression in elite and viremic HIV-1 controllersAgathe León, Felipe García, Ignacio Pérez et al.|AIDS|2016Cited by 84
Factors Leading to the Loss of Natural Elite Control of HIV-1 InfectionMaría Pernas, Ezequiel Ruíz-Mateos, Beatriz Domínguez-Molina et al.|Journal of Virology|2017Cited by 78
Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressorsMaría Salgado, José M. Benito, Norma Rallón et al.|Clinical Immunology|2011Cited by 75
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Constanza Lucero, Núria Climent et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 65